All News

What We Mean When We Say "Skin of Color" in Dermatology: A Closer Look with Raj Chovatiya, MD, PhD, MSCI
March 19, 2025

Chovatiya, expert clinical dermatologist and researcher, points out that the term "skin of color" comprises a heterogenous set of topics, in an interview at AAD 2025.

Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care
March 18, 2025

In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.

Antibiotics, NSAIDs Reported Most Common Cause of Pediatric Anaphylaxis
March 18, 2025

Among pediatric patients aged 1 month to 18 years with emergent anaphylaxis, cephalosporins were the leading antibiotics and ibuprofen the top NSAID implicated in a new study.

Osteoporosis Risk Screening Tools Fall Short in Younger Postmenopausal Women, New Research Reveals
March 18, 2025

Three of the 5 osteoporosis screening tools recommended by the USPSTF for identifying osteoporosis in postmenopausal women aged 50 yo 64 years proved suboptimal.

Topical Steroid Withdrawal: Study Identifies Mitochondrial Dysfunction as a Potential Target for Treatment
March 18, 2025

NIH researchers also proposed new diagnostic criteria that include a combination of major and minor symptoms, offering improved sensitivity for identifying TSW cases.

FDA Greenlights First Rivaroxaban Generics (2.5 mg): Daily Dose
March 18, 2025

Your daily dose of the clinical news you may have missed.

Antihistamines Are a Poor Option to Treat Eczema in Older Adults: Clinical Pearl
March 18, 2025

Antihistamines for itch caused by disorders like atopic dermatitis pose more problems, like sedation and fall risk, than they provide relief, according to Daniel Butler, MD.

Early Responsive Parenting Intervention Shows Modest, Short-Term Impact on Childhood Obesity
March 17, 2025

New data shows that early-life responsive parenting can lower childhood BMI, but effects diminished by age 9, highlighting the need for ongoing obesity prevention efforts.

Povorcitinib Efficacy in 2 Pivotal Phase 3 Trials Will Support Global Regulatory Submission for Hidradenitis Suppurativa
March 17, 2025

Both trials met their primary endpoints, demonstrating a statistically significant improvement in HiSCR50 compared to placebo, with a favorable safety profile, according to Incyte.

Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy
March 17, 2025

Elizabeth Swanson, MD, shares how the rise of T.indotineae, a terbinafine-resistant fungal species, has shifted her treatment approach.